1370 KB23 KB1410 KB23 KB192920262021Troha, AlešVesnaver, Alešštevilka:1/2letnik:90str. 3-9DOI:10.6016/ZdravVestn.3030ISSN:1318-0347COBISSID:54208515URN:URN:NBN:SI:doc-JLXR2UOYslSlovensko zdravniško društvoZdravniški vestnikbruksizembruxismhipertrofija masetrnih mišicmasseteric hypertrophymialgijamyalgiazdravljenjeZdravljenje bruksizma, mialgij in hipertrofij masetrnih mišic z botulinskim toksinom tipa A| Treatment of bruxism, masseteric myalgia and hypertrophy with botulinum toxin type A|Background: Bruxism (nocturnal dental clenching and grinding) is a persistent problem that affects many systems, and is difficult to treat. It causes pathological abrasions and dental injuries, as well as fractures of prosthodontic reconstructions, painful hypertrophy of masticatory muscles, and sometimes temporomandibular joint pains and headaches. Intramuscular botulinum toxin injections have been reported as a safe and effective means of treatment, causing revers ible weakening of the masticatory muscles, which results in symptomatic relief. Patients and methods: A retrospective analysis of the time period 2007 - 2018 was made, in which 72 patients with bruxism, masseteric myalgia and hypertrophy were treated with botulinum toxin injections. Results: The majority of patients (58 of 64, i.e. 91%) reported symptomatic reliefpain diminished or subsided as did nocturnal bruxism, the masseters softened and lost volume. The effects of botulin toxin last 4 - 6 months, but in 29 (50%) patients, symptomatic relief was permanent and they did not returnTEXTznanstveno časopisjejournalsSlovenian National E-content AggregatorNational and University Library of SloveniaSlovensko zdravniško društvo